Verastem Inc (STU:2VS)
€ 5.78 -0.41 (-6.62%) Market Cap: 528.73 Mil Enterprise Value: 484.17 Mil PE Ratio: 0 PB Ratio: 12.35 GF Score: 30/100

Verastem Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 20, 2026 / 01:30 PM GMT
Release Date Price: €3.53 (-2.57%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

VSTM.OQ - Verastem Inc
Verastem Inc at RBC Capital Markets Global Healthcare Conference
May 20, 2026 / 01:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
RBC Global Healthcare Conference, we've got Veristem, represented by Dan and Dan, Patterson Lyons, their CEO and Chief Commercial Officer. Thanks for being here.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Happy to be here and great to have an opportunity for folks to meet Dan, or Dan two, or you're probably Dan three, I guess.

--------------------------------------------------------------------------------
Unidentified_1 [3]
--------------------------------------------------------------------------------
Yeah, there's a lot of Dan's. It's
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot